The Street Sweeper has an excellent track record in exposing corporate fraud and presenting compelling short opportunities. Their latest story is very interesting and worth reading.
Coronado Biosciences (NASDAQ: CNDO) is tangled amid a bizarre whipworm therapeutic candidate, jail birds, cozy relationships, crazy financing, decimated companies controlled by a master puppeteer – and just now a brand new $200 million shelf registration.
And it’s all precisely timed. The company is rolling out public stock offerings – and filed the new S-3 that will further dilute the stock with millions upon millions of additional shares – just before clinical trial results are released.
Is this because CNDO suspects its key candidate – live pig whipworm eggs – won’t work? Does the company suspect that it will never even reach phase III?
Source: The Street Sweeper